謝瑩

藥學院(SP)

ORCID:

ResearcherID:

成果: 132 件 | 合作者:335 

WOS核心合集引用:2040 | H Index:23 | WOS收錄:83

CNKI收錄:7 | SCOPUS收錄:82

論文: 110  |  科研項目:5  |   專利:17

論文: 110 篇 上傳 編輯 糾錯 可能是謝瑩的文章 匯出

1.Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism

Xie, Ying, Feng, Sen     More...

Phytomedicine[0944-7113], Published 2021, Volume 80,

收錄情况: WOS SCOPUS

WOS核心合集引用: 2  2019影響因子:  4.268 

2.Early lung cancer diagnostic biomarker discovery by machine learning methods

Xie, Ying, Meng, Wei     More...

Translational Oncology[1936-5233], Published 2021, Volume 14, Issue 1,

收錄情况: WOS SCOPUS

WOS核心合集引用: 1  2019影響因子:  3.558 

3.Structural characterization and hepatoprotective activity of a galactoglucan from Poria cocos

Cheng, Yue, Wang, Le     More...

Carbohydrate Polymers[0144-8617], Published 2021, Volume 263,

收錄情况: WOS SCOPUS

2019影響因子:  7.182 

4.Wutou decoction ameliorates experimental rheumatoid arthritis via regulating NF-kB and Nrf2: Integrating efficacy-oriented compatibility of traditional Chinese medicine

Xie, Ying, Mai, ChuT     More...

Phytomedicine[0944-7113], Published 2021, Volume 85,

收錄情况: WOS SCOPUS

2019影響因子:  4.268 

5.Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases

Huo, Shuai, Yan, Mei     More...

ACS Omega[2470-1343], Published 2021, Volume 6, Issue 14, Pages 9500-9508

收錄情况: WOS SCOPUS

2019影響因子:  2.870 

6.Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: Pharmacokinetic and pharmacological study

Feng, SenLing, Qu, B     More...

Phytomedicine[0944-7113], Published 2020, Volume 67,

收錄情况: WOS SCOPUS

WOS核心合集引用: 2  2019影響因子:  4.268 

7.Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism

Suguro, Rinkiko, Yua     More...

Pharmacological Research[1043-6618], Published 2020, Volume 151,

收錄情况: WOS SCOPUS

WOS核心合集引用: 4  2019影響因子:  5.893 

8.Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents

Feng, Senling, Zheng     More...

Acta Pharmaceutica Sinica B[2211-3835], Published 2020, Volume 10, Issue 2, Pages 327-343

收錄情况: WOS SCOPUS

WOS核心合集引用: 8  2019影響因子:  7.097 

9.Discovery of chemical markers for identifying species, growth mode and production area of Astragali Radix by using ultra-high-performance liquid chromatography coupled to triple quadrupole mass spectrometry

Wang, CanJian, He, F     More...

Phytomedicine[0944-7113], Published 2020, Volume 67,

收錄情况: WOS SCOPUS

WOS核心合集引用: 6  2019影響因子:  4.268 

10.Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study

Feng, SL, Luo, HB, C     More...

JOURNAL OF GINSENG RESEARCH[1226-8453], Published 2020, Volume 44, Issue 2, Pages 247-257

收錄情况: WOS SCOPUS

WOS核心合集引用: 5  2019影響因子:  5.487 

成果: 5 匯出
Project
成果: 17 匯出

1.METHOD OF INHIBITING OR TREATING CARDIOVASCULAR DISORDER

ZHOU Hua, ZUO Yihan,     More...

專利權人: Macau University of     More...

申請號: AU2019101081 申請日: 2019/9/19

公開(公告)號: AU2019101081A4 公開(公告)日期: 2019/10/31

IPC分類號: A61K31/36; A61P9/10

法律狀態: 有效

同族信息: AU2019101081A4

2.METHODS AND COMPOSITIONS FOR TREATING MULTIDRUG-RESISTANT CANCER

XIE Ying, JIANG Zhi     More...

專利權人: Macau University of     More...

申請號: AU2018101071 申請日: 2018/8/2

公開(公告)號: AU2018101071A4 公開(公告)日期: 2018/9/13

IPC分類號: A61K31/704; A61K8/63; A61P35/00; C07J17/00

法律狀態: 有效

同族信息: CN110787173A; AU2018101071A4

3.Methods for Treating Cancer

MA Wenzhe, XIE Ying,     More...

專利權人: Macau University of     More...

申請號: AU2018100066 申請日: 2018/1/16

公開(公告)號: AU2018100066A4 公開(公告)日期: 2018/2/15

IPC分類號: A61K31/381; A61P35/00; C07D333/36

法律狀態: 有效

同族信息: US20190183856A1; AU2018100066A4

4.Method of increasing the bioavailability of silybin

XIE Ying, LIU Liang,     More...

專利權人: Macau University of     More...

申請號: AU2017101224 申請日: 2017/9/6

公開(公告)號: AU2017101224A4 公開(公告)日期: 2017/10/5

IPC分類號: A61K31/357; A61K31/352; A61P1/16

法律狀態: 有效

同族信息: US10265298B2; AU2017101224A4; US20190060273A1; CN109419799A

5.Method of increasing the bioavailability of silybin

Ying XIE, Liang LIU,     More...

專利權人: Macau University of     More...

申請號: US15682564 申請日: 2017/8/22

公開(公告)號: US20190060273A1 公開(公告)日期: 2019/2/28

IPC分類號: A61K31/357; A61K9/00; A61K9/20; A61K31/352

法律狀態: 授权

同族信息: US10265298B2; AU2017101224A4; US20190060273A1; CN109419799A

6.FLAVONOLIGNANS FOR TREATMENT OF AUTOIMMUNE INFLAMMATORY DISEASES

Ying Xie, Liang Liu,     More...

專利權人: Macau University of     More...

申請號: US15481720 申請日: 2017/4/7

公開(公告)號: US20180289666A1 公開(公告)日期: 2018/10/11

IPC分類號: A61K31/366

法律狀態: 暂缺

同族信息: US20180289666A1

7.Flavonolignans for treatment of autoimmune inflammatory diseases

XIE Ying, LIU Liang,     More...

專利權人: Macau University of     More...

申請號: AU2017100396 申請日: 2017/4/7

公開(公告)號: AU2017100396A4 公開(公告)日期: 2017/5/18

IPC分類號: A61K31/357; A61K31/352; A61P43/00

法律狀態: 有效

同族信息: AU2017100396A4

8.METHOD OF TREATING BREAST CANCER

MA Wenzhe, XIE Ying,     More...

專利權人: Macau University of     More...

申請號: AU2017101728 申請日: 2017/12/7

公開(公告)號: AU2017101728A4 公開(公告)日期: 2018/1/18

IPC分類號: G01N33/48; C12Q1/68; G01N33/574

法律狀態: 有效

同族信息: AU2017101728A4

9.METHODS FOR TREATING CANCER

Wenzhe MA, Ying XIE,     More...

專利權人: Macau University of     More...

申請號: US15846129 申請日: 2017/12/18

公開(公告)號: US20190183856A1 公開(公告)日期: 2019/6/20

IPC分類號: A61K31/381; A61P35/00; G01N33/574

法律狀態: 未授权失效

同族信息: US20190183856A1; AU2018100066A4

10.USE OF NOBILETIN IN CANCER TREATMENT

Wen zhe MA, Sen ling     More...

專利權人: Macau University of     More...

申請號: US15415883 申請日: 2017/1/26

公開(公告)號: US20170143668A1 公開(公告)日期: 2017/5/25

IPC分類號: A61K31/366; A61K31/337; A61K31/704

法律狀態: 未授权失效

同族信息: US20170143668A1; US20170027901A1; AU2015101287A4; US9808477B2

本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

Copyright © 2018 澳門科技大學學者庫